Related Experiment Videos
ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective
R J Falk1, P H Nachman, S L Hogan
1Department of Medicine, University of North Carolina, Chapel Hill, USA. Ronald_Falk@med.unc.edu
Seminars in Nephrology
|June 16, 2000
Summary
ANCA-associated small vessel vasculitis, including microscopic polyangiitis and granulomatosis with polyangiitis, involves small blood vessels and is diagnosed by autoantibodies. Early diagnosis and prompt treatment with corticosteroids and cyclophosphamide are crucial for remission and improved prognosis.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Microscopic polyangiitis, Wegener's granulomatosis, Churg-Strauss syndrome, and pauci-immune necrotizing glomerulonephritis are related small vessel vasculitides.
- These conditions share pathological and clinical features, primarily affecting small blood vessels and often associated with autoantibodies to myeloperoxidase (MPO-ANCA) or proteinase 3 (PR3-ANCA).
Purpose of the Study:
- To review the pathogenesis, clinical manifestations, diagnostic markers, and treatment strategies for ANCA-associated small vessel vasculitis and glomerulonephritis.
- To highlight the importance of early diagnosis and prompt treatment for improving patient outcomes.
Main Methods:
- Review of existing literature on ANCA-associated small vessel vasculitis.
- Analysis of clinical presentations, diagnostic criteria (including ANCA testing), and treatment outcomes.
Main Results:
- ANCA-associated vasculitis presents with diverse clinical manifestations affecting kidneys, respiratory tract, lungs, and skin.
- Focal necrotizing glomerulonephritis with crescent formation is characteristic of renal involvement.
- Pulmonary hemorrhage and entry serum creatinine are key prognostic markers; high doses of corticosteroids and cyclophosphamide are primary treatments, with plasmapheresis beneficial for pulmonary hemorrhage.
Conclusions:
- Early diagnosis and prompt initiation of therapy, primarily corticosteroids and cyclophosphamide, are critical for achieving remission in ANCA-associated small vessel vasculitis.
- Despite treatment advances, long-term prognosis depends on rapid diagnosis and timely intervention to prevent end-stage renal disease and other complications.